Skip to main content

Immunoreconstitution by Bone Marrow Transplantation Decreases Lymphoproliferative Malignancies in Wiskott-Aldrich and Severe Combined Immune Deficiency Syndromes

  • Chapter
Immune Deficiency and Cancer

Abstract

Data linking immunodeficient individuals to a high incidence of malignancy has been collected through the analysis of outcomes in renal allograft recipients (1) and patients with naturally occurring immunodeficiency states such as severe combined immune deficiency (SCID), Wiskott-Aldrich syndr ome (WAS) and ataxia telangiectasia (2–4). The mechanisms involved in the pathogenesis of malignancy in patients with naturally occurring or acquired immunodeficiencies are poorly understood. In large part this is due to the heterogeneity in the scope and severity of immune deficiency in these patients. In addition, some patients are exposed to potentially oncogenic agents, such as Epstein-Barr virus (EBV), that may influence the development of malignancy. Despite the complexity of these patients, certain aspects of the relationship between naturally occurring immune deficiency and malignancy can be studied. Many patients with SCID and WAS have been successfully immunoreconstituted by bone marrow transplantation (BMT). Therefore, it has become possible to ask whether immunoreconstitution prevents the development of malignancy in these patients. This chapter addresses this question by analyzing cases of malignancy in immunodeficient individuals that have undergone either BMT or thymus transplantation. These data will be compared to previously reported cases of malignancies in untransplanted immunodeficient patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Penn, I. Malignancies associated with immunosuppressive or cytotoxic therapy. Surgery, 83:294, 1978.

    Google Scholar 

  2. Kersey, J., Spector, B., and Good, R. Primary immunodeficiency diseases and cancer: the Immunodeficiency-Cancer Registry. Int. J. Cancer, 12:333, 1973.

    Article  PubMed  CAS  Google Scholar 

  3. Filipovich, A.H., Zerbe, D., Spector, B., and Kersey, J. Lymphomas in persons with naturally occurring immunodeficiency disorders. In: I.T. Magrath (ed.), The Influence of the Environment on Leukemia and Lymphoma Subtypes. New York: Raven Press, 1983.

    Google Scholar 

  4. Spector, B.D., Perry, G., and Kersey, J.H. Genetically determined immunodeficiency diseases (GDID) and malignancy: report from the Immunodeficiency-Cancer Registry. Clin. Immunol. Immunopathol., 11:12, 1978.

    Article  PubMed  CAS  Google Scholar 

  5. Bortin, M. and Rimm, A. Severe combined immunodeficiency disease. Characterization of the disease and results of transplantation. J. Am. Med. Assoc, 238:591, 1977.

    Article  CAS  Google Scholar 

  6. Hong, R. Present and future status of thymus transplantation. Ann. Clin. Res., 13:350, 1981.

    PubMed  CAS  Google Scholar 

  7. Borzy, M.S., Hong, R., Horowitz, S.D., Gilbert, E., Kaurman, D., De Mendonca, W., Oxelius, V.A., Dictor, M., and Pachman, L. Fatal lymphoma after transplantation of cultured thymus in children with combined immunodeficiency disease. N. Engl. J. Med., 301:565, 1979.

    Article  PubMed  CAS  Google Scholar 

  8. Frizzera, G., Rosai, J., Dehner, L., Spector, B.D., and Kersey, J.H. Lymphoreticular disorders in primary immunodeficiencies: new findings based on an up-to-date histologic classification of 35 cases. Cancer, 46:692, 1980.

    Article  PubMed  CAS  Google Scholar 

  9. Kapoor, N., Kirkpatrick, D., Blaese, R., Oleske, J., Hilgartner, M., Changanti, R., Good, R., and O’Reilly, R. Reconstitution of normal megakaryocytopoiesis and immunologic functions in Wiskott-Aldrich syndrome by marrow transplantation following myeloablation and immunosuppression with busulfan and cyclophosphamide. Blood, 57:692, 1981.

    PubMed  CAS  Google Scholar 

  10. Bach, H.F., Albertini, R. J., Joo, P., Anderson, J.L., and Bortin, M.M. Bone marrow transplantation in a patient with the Wiskott-Aldrich syndrome. Lancet, ii:1364, 1968.

    Article  Google Scholar 

  11. August, C.S., Hathaway, W.W., Githens, J.H., Pearlman, D., Mcintosh, K., and Favara, B. Improved platelet function following bone marrow transplantation in an infant with Wiskott-Aldrich syndrome. J. Pediat., 82:58, 1973.

    Article  PubMed  CAS  Google Scholar 

  12. Meuwissen, H.J., Kieserman, E.G., Taft, B., Pollara, B., and Pickering, R.J. Marrow transplantation in Wiskott-Aldrich syndrome: T cell engraftment with cyclophosphamide. Complete engraftment with total body irradiation. Pediat. Res., 12:483, 1978.

    Article  Google Scholar 

  13. Parkman, R., Rappaport, D., Geha, R., Cassady, R., Levey, R., Nathan, D.G., Belli, J., and Rosen, F. Complete correction of the Wiskott-Aldrich syndrome by allogeneic bone marrow transplantation. N. Engl. J. Med., 298:921, 1978.

    Article  PubMed  CAS  Google Scholar 

  14. Hanto, D., Sakamoto, K., Purtilo, D.T., Simmons, R., and Najarian, J. The Epstein-Barr virus in the pathogenesis of post transplant lymphoproliferative disorders. Surgery, 90:204, 1981.

    PubMed  CAS  Google Scholar 

  15. Thestrup-Pedersen, K., Esmann, V., Jensen, J.R., Hastrup, J., Thorling, K., Saemundsen, A.K., Bisballe, S., Oallesen, G., Madsen, M., Grazia-Masucci, M., and Emberg, I. Epstein-Barr virus-induced lymphoproliferative disorder converting to fatal Burkitt-like lymphoma in a boy with interferon inducible chromosomal defect. Lancet, ii:997, 1980.

    Article  Google Scholar 

  16. Taylor, A., Harnden, D., Arlett, C., Harcourt, S., Lehmann, A., Stevens, S., and Bridges, B. Ataxia telangiectasia: a human mutation with abnormal radiation sensitivity. Nature, 258:427, 1975.

    Article  PubMed  CAS  Google Scholar 

  17. Filipovich, A.H. and Spector, B.D. Immunodeficiency (ID) as a susceptibility factor for malignancy in ataxia telangiectasia (AT): report from the Immunodeficiency-Cancer Registry (ICR). Pediat. Res., 15(4):806, 1981.

    Google Scholar 

  18. Tsoi, M. Immunological mechanisms of graft-versus-host disease in man. Transplantation, 33:459, 1982.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Plenum Publishing Corporation

About this chapter

Cite this chapter

Neudorf, S.M.L., Filipovich, A.H., Kersey, J.H. (1984). Immunoreconstitution by Bone Marrow Transplantation Decreases Lymphoproliferative Malignancies in Wiskott-Aldrich and Severe Combined Immune Deficiency Syndromes. In: Purtilo, D.T. (eds) Immune Deficiency and Cancer. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4760-6_24

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-4760-6_24

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-4762-0

  • Online ISBN: 978-1-4684-4760-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics